Fred Hutch Obliteride celebrated our 10th year this August — and this community came out with a record-breaking, heart-filling show of joy and connection. THANK YOU!
After two years of being apart, the energy on Obliteride weekend was amazing. From dancing at the Friday Night Party to cheering folks across the finish line on Obliteride Day, our in-person event in Seattle was unforgettable. And from Austin to Atlanta and Canada to Croatia, our virtual challengers showed us how it’s done — biking, kayaking, knitting and more.
This season, we welcomed a record-setting 5,500 participants and 430 volunteers on more than 450 teams. And, together with our sponsors, donors, and partners, we raised more than $4.8 million dollars — our largest fundraising amount ever — for innovative science at Fred Hutchinson Cancer Center.
Obliteriders: we are so grateful. We could not do any of this without you.
I hope you’ll enjoy reading this exciting 2022 report. It’s a great way to get to get know your fellow participants, meet some of our sponsors, and learn about the work you support.
Even more importantly: I hope you’ll feel proud of all you’ve accomplished this year. On behalf of myself, the Obliteride team, and everyone at Fred Hutchinson Cancer Center: Thank you. We are honored that you're part of this community and inspired by your dedication to helping Fred Hutch cure cancer faster. See you next year!
“I couldn't be more proud to support the lifesaving research at Fred Hutch. But this year it's personal. In December , I was diagnosed with breast cancer. In my 17 years of working at Fred Hutch I have seen the advances we've made. That's why I participate year in and year out, and why I participated this year — with my amazing sister by my side.”
Raised to support
(a new record!)
Fred Hutch employee participants and volunteers
Participants who raised $1,000 or more
Fred Hutch researchers supported
Impressions on social media
Social media followers
Over the last 10 years, the Obliteride community has fueled more than $40 million in breakthrough work at Fred Hutch. With your partnership, Fred Hutch scientists, clinicians, and staff are advancing prevention, treatment, care, and cures for cancer and infectious diseases — and improving countless lives.
Our goal? A healthier life for every person in every community.
From first-time Obliteriders to 10-year participants, our event united thousands of people in 2022.
WHY WE PARTICIPATE
Whether they joined to have fun, honor loved ones, be part of a company team, or for another reason, every participant made a difference.
HOW WE PARTICIPATED
Whether they joined us in Seattle or picked their own virtual challenges, Obliteriders went all-out for cancer cures in 2022! Here’s a look at how participants joined up this year.
It all starts with a simple question: “Will you support my Obliteride?” Whether participants raised $1 or $10,000, their fundraising — and the support of their donors — fuels breakthrough research at Fred Hutch. THANK YOU! As of November 1, 2022.
Fred Hutch researchers, clinicians, and staff count on Obliteride to support world-changing science — and our community answers the call! Thanks to our generous sponsors, 100% of every participant-raised dollar goes right to work.
Our 2022 Obliteride-funded researchers are harnessing the immune system to fight cancer and infectious diseases. Learning how tumors start and spread. Developing new treatments and making those we have more personalized and effective. And pushing the limits of scientific discovery to improve and save lives.
Meet the researchers you support:
Learning how cells fix their broken DNA to understand cancer origins and inform new therapies.
Understanding our immune response to new and evolving viruses to improve treatments for current and emerging threats.
Developing therapies that optimize the cancer-fighting power of immune T cells while reducing side effects.
Studying how a type of bacteria leads to aggressive colorectal cancer to better prevent and treat it.
Improving screening by identifying genetic and other risk factors for prostate cancer in diverse populations.
Learning how immune T cells behave during and after treatment to improve immune-based therapies for children.
Refining blood stem cell transplantation and testing it to treat severe autoimmune diseases.
Researching mosquito- and tick-borne flaviviruses, including dengue and Zika, that threaten people worldwide.
Linking cellular changes to different prostate tumor pathologies to enhance diagnosis.
Illuminating the role of glia, which form one-half of our brain cells, in Alzheimer’s and autism.
Distilling complex genetic and environmental factors to better predict disease risk.
Uncovering how blood stem cells repopulate the bone marrow after radiation and transplant.
Improving stem cell transplantation and follow-up to catch relapse early.
Designing new immunotherapies that harness immune T cells to fight lung and skin cancers.
Harmonizing medical records and study data to recommend changes in disease diagnosis and public health measures.
Fred Hutchinson Cancer Center is an independent, nonprofit organization that serves as UW Medicine’s cancer program. This unique relationship creates a powerful team for adults facing cancer. Fred Hutch unites comprehensive cancer care with advanced scientific research to provide the latest cancer treatment options and accelerate discoveries that prevent, treat and defeat cancer and infectious diseases worldwide. Fred Hutch is the only National Cancer Institute-designated cancer center in Washington and has earned a global reputation for discoveries in cancer, infectious disease and basic research, including important advances in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services and has network affiliations with hospitals in four states. Our work includes:
Rajiv Chopra, a vice president of software development at Amazon, describes himself as “a do-er.” He also knows many people affected by cancer. So, when a coworker asked him to join Obliteride as an executive sponsor in 2019, he didn’t have to think long before accepting.
This year, with fellow Amazon executive sponsors Jon Jones, Maureen Lonergan, and David Zapolsky, Chopra stepped up to renew Amazon’s global sponsorship. Amazon and Amazon employees raised over $550,000 to fuel cancer care and research. “Cancer research is as worthy a cause as any, and one where I thought I could be more personally involved,” said Chopra.
Alexandria Real Estate Equities
Freestone Capital Management
Silver Creek Capital Management
Lease Crutcher Lewis
Thermo Fisher Scientific
We can’t wait to connect with you again for Obliteride 2023: Saturday, August 12. Join up, make a difference, and help cure cancer faster!